Total planned funding: $860,724,367
Clear active filters
Partnership for Supply Chain Management
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Allocations
Countries/Regions
| Nigeria | $186,923,038 |
| Zambia | $107,642,028 |
| Mozambique | $95,272,887 |
| Tanzania | $81,419,939 |
| Côte d'Ivoire | $70,665,408 |
| Uganda | $53,657,279 |
| Ethiopia | $50,251,543 |
| Zimbabwe | $44,810,383 |
| Haiti | $44,807,056 |
| Rwanda | $36,737,462 |
| Kenya | $21,788,750 |
| Vietnam | $21,591,559 |
| Botswana | $11,727,065 |
| South Africa | $11,432,678 |
| Guyana | $5,853,749 |
| Malawi | $4,536,312 |
| South Sudan | $3,122,349 |
| Democratic Republic of the Congo | $2,719,133 |
| Namibia | $2,282,062 |
| Burundi | $1,627,079 |
| Central America Region | $1,028,000 |
| Cameroon | $450,000 |
| Ghana | $350,000 |
| Eswatini | $28,608 |
| Dominican Republic | $0 |
Organizational Types
| Private Contractor | $838,618,532 |
| Implementing Agency | $22,105,835 |
Program Areas
| Treatment | $503,845,952 |
| Governance and Systems | $175,921,158 |
| Prevention | $73,247,286 |
| Care | $60,438,380 |
| Testing | $47,271,591 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $446,319,015 |
| HLAB: Laboratory Infrastructure | $89,481,792 |
| OHSS: Health Systems Strengthening | $80,369,350 |
| HTXS: Treatment: Adult Treatment | $52,453,283 |
| HBHC: Care: Adult Care and Support | $48,104,286 |
| HVCT: Testing: HIV Testing and Counseling | $47,271,591 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $28,312,954 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,947,406 |
| HMIN: Biomedical Prevention: Injection Safety | $10,695,757 |
| HVTB: Care: TB/HIV | $6,672,980 |
| HMBL: Biomedical Prevention: Blood Safety | $6,223,609 |
| HVSI: Strategic Information | $6,070,016 |
| PDTX: Treatment: Pediatric Treatment | $5,073,654 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $4,317,314 |
| PDCS: Care: Pediatric Care and Support | $4,139,462 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,750,246 |
| HKID: Care: Orphans and Vulnerable Children | $1,521,652 |